Page 3 - Nyse Ebs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Boulder Hill Capital Management LP bought a new position in shares of Emergent BioSolutions Inc. (NYSE:EBS – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 40,600 shares of the biopharmaceutical company’s stock, valued at approximately $421,000. […]

Emergent has officially shipped its over the counter, original prescription strength NARCAN® Naloxone HCl Nasal Spray 4 mg to leading mass, drug/pharmacy...

StockNews.com initiated coverage on shares of Emergent BioSolutions (NYSE:EBS – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Emergent BioSolutions Trading Down 2.9 % Shares of EBS stock opened at $4.97 on Thursday. The company has a debt-to-equity ratio of 0.47, a quick […]

Emergent BioSolutions (NYSE:EBS – Get Free Report) is set to release its earnings data after the market closes on Tuesday, August 8th. Analysts expect Emergent BioSolutions to post earnings of ($0.95) per share for the quarter. Emergent BioSolutions has set its FY 2023 guidance at EPS.Individual that are interested in registering for the company’s earnings […]

Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) have earned a consensus rating of “Hold” from the five analysts that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the […]